These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 26420479)
1. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways. Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479 [TBL] [Abstract][Full Text] [Related]
2. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Mimata Y; Kamataki A; Oikawa S; Murakami K; Uzuki M; Shimamura T; Sawai T Int J Rheum Dis; 2012 Feb; 15(1):36-44. PubMed ID: 22324945 [TBL] [Abstract][Full Text] [Related]
4. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Hashizume M; Hayakawa N; Mihara M Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis. Wen H; Liu Y; Li J; Wei D; Liu D; Zhao F Clin Exp Rheumatol; 2018; 36(5):798-805. PubMed ID: 29465363 [TBL] [Abstract][Full Text] [Related]
6. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation. Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151 [TBL] [Abstract][Full Text] [Related]
7. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis. Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742 [TBL] [Abstract][Full Text] [Related]
8. Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis. Lee KA; Kim KW; Kim BM; Won JY; Min HK; Lee DW; Kim HR; Lee SH Arthritis Res Ther; 2019 Dec; 21(1):283. PubMed ID: 31831038 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis. Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876 [TBL] [Abstract][Full Text] [Related]
10. Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway. Niu HQ; Zhao WP; Zhao XC; Luo J; Qin KL; Chen KL; Li XF Int Immunopharmacol; 2018 Aug; 61():45-53. PubMed ID: 29803913 [TBL] [Abstract][Full Text] [Related]
11. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis. Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214 [TBL] [Abstract][Full Text] [Related]
12. Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation. Umar S; Hedaya O; Singh AK; Ahmed S Toxicol Appl Pharmacol; 2015 Sep; 287(3):299-305. PubMed ID: 26134265 [TBL] [Abstract][Full Text] [Related]
13. N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis. Kim HR; Kim KW; Kim BM; Lee KA; Lee SH Korean J Intern Med; 2019 Jan; 34(1):210-219. PubMed ID: 28286938 [TBL] [Abstract][Full Text] [Related]
14. TACE-dependent amphiregulin release is induced by IL-1β and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis. Liu FL; Wu CC; Chang DM Rheumatology (Oxford); 2014 Feb; 53(2):260-9. PubMed ID: 24196392 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096 [TBL] [Abstract][Full Text] [Related]
16. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344 [TBL] [Abstract][Full Text] [Related]
17. Interleukin 17 regulates SHP-2 and IL-17RA/STAT-3 dependent Cyr61, IL-23 and GM-CSF expression and RANKL mediated osteoclastogenesis by fibroblast-like synoviocytes in rheumatoid arthritis. Ganesan R; Rasool M Mol Immunol; 2017 Nov; 91():134-144. PubMed ID: 28898718 [TBL] [Abstract][Full Text] [Related]
18. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim HR; Kim BM; Cho ML; Lee SH Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Kwok SK; Cho ML; Park MK; Oh HJ; Park JS; Her YM; Lee SY; Youn J; Ju JH; Park KS; Kim SI; Kim HY; Park SH Arthritis Rheum; 2012 Mar; 64(3):740-51. PubMed ID: 21968544 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Tian J; Chen JW; Gao JS; Li L; Xie X Rheumatol Int; 2013 Jul; 33(7):1829-35. PubMed ID: 23328930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]